Table 2 Patient and clinicopathological characteristics of 15 recurrent cases
Case | Group | Age | Sex | Tumor location | T stage | Ly | v | HM | VM | Months to disease recurrence (site) |
|---|---|---|---|---|---|---|---|---|---|---|
1 | CRT | 69 | Male | Middle thorax | T1b-SM2 | (+) | (−) | (−) | (−) | 9 (Local) |
2 | CRT | 60 | Male | Middle thorax | T1b-SM2 | (+) | (−) | (+) | (−) | 24 (Distant) |
3 | CRT | 68 | Male | Middle thorax | T1b-SM1 | (+) | (−) | (−) | (−) | 11 (Local) |
4 | CRT | 60 | Male | Middle thorax | T1a-MM | (+) | (−) | (−) | (−) | 42 (Local)* |
5 | CRT | 80 | Male | Lower thorax | T1b-SM2 | (+) | (+) | (−) | (+) | 32 (Local)* |
6 | CRT | 62 | Male | Upper thorax | T1b-SM2 | (−) | (+) | (−) | (−) | 50 (Local) |
7 | CRT | 71 | Male | Middle thorax | T1a-MM | (+) | (+) | (−) | (−) | 9 (Local)* |
8 | CRT | 59 | Female | Upper thorax | T1b-SM1 | (+) | (−) | (−) | (+) | 18 (Distant) |
9 | CRT | 73 | Male | Middle thorax | T1b-SM2 | (+) | (+) | (−) | (−) | 9 (Regional LN) |
10 | CRT | 76 | Male | Cervix | T1a-MM | (+) | (−) | (−) | (−) | 9 (Local) |
11 | Esophagectomy | 78 | Male | Lower thorax | T1b-SM2 | (+) | (−) | (−) | (−) | 29 (Distance) |
12 | Esophagectomy | 58 | Male | Middle thorax | T1b-SM1 | (+) | (−) | (−) | (−) | 38 (Distance) |
13 | Esophagectomy | 70 | Male | Middle thorax | T1b-SM2 | (+) | (+) | (−) | (−) | 48 (Regional LN) |
14 | Esophagectomy | 63 | Male | Middle thorax | T1b-SM2 | (+) | (−) | (−) | (−) | 36 (Regional LN) |
15 | Esophagectomy | 74 | Male | Middle thorax | T1a-MM | (+) | (−) | (−) | (−) | 35 (Anastomotic) |